Innovent Biologics Limited will hold a special shareholders meeting on June 21, 2024, at the administration building of Innovent Biologics located in China Suzhou Industrial Park. The meeting will handle a number of ordinary resolution cases, including confirming the restricted shares granted to senior management such as Dr. Yu Dechao, Mr. Xi Hao, Ms. Xu Yiyin, Dr. Charles Leland Cooney, Dr. Chen Kai, Mr. Gary Zieziula and Mr. Chen Shuyun according to the restricted stock plan provisions on March 20-22 and May 3, 2024. In addition, the adoption of a new stock plan called the 2024 Stock Plan will be considered, and related plan authorization limits will be discussed. The voting results of the special shareholders meeting will be announced in accordance with the listing rules.

Innovent Biologics Limited will hold a special shareholders meeting on June 21, 2024, at the administration building of Innovent Biologics located in China Suzhou Industrial Park. The meeting will handle a number of ordinary resolution cases, including confirming the restricted shares granted to senior management such as Dr. Yu Dechao, Mr. Xi Hao, Ms. Xu Yiyin, Dr. Charles Leland Cooney, Dr. Chen Kai, Mr. Gary Zieziula and Mr. Chen Shuyun according to the restricted stock plan provisions on March 20-22 and May 3, 2024. In addition, the adoption of a new stock plan called the 2024 Stock Plan will be considered, and related plan authorization limits will be discussed. The voting results of the special shareholders meeting will be announced in accordance with the listing rules.